期刊文献+

角膜移植术后免疫排斥反应的探讨 被引量:4

A clinical evaluation of immunological rejection following corneal transplantation
下载PDF
导出
摘要 目的 为有效控制角膜移植术后免疫排斥反应的发生 ,探讨角膜移植术后免疫排斥反应发生的因素。方法 对角膜移植手术术后发生排斥反应者进行分析 ,总结发生的原因、时间、程度等。结果  12 3眼中发生免疫排斥反应者 46眼(3 7 4% ) ,其中 17眼发生不可逆的排斥反应 ,占排斥反应的 3 6.96% ;有角膜新生血管者发生排斥反应 41眼 ,占 89 13 %。内皮型排斥反应 2 0眼 ,上皮型 12眼 ,基质型 3眼 ,混合型 11眼。排斥反应发生时间为术后 3周~ 3年 ,术后 3~ 6月发生率最高 ,占 46.48%。结论 免疫排斥反应的发生是多因素参与的复杂过程 ,与角膜新生血管的数量、角膜受损及感染的程度、植片的大小。 Objective To evaluate the correlative factors of immunological rejection follwing corneal transplantation for controlling the immunological rejection.Methods In 123 eyes were performed on corneal transplantation, immunological rejection emerged in 46 eyes,the reason,time and degree was summarized.Results The incidence of immunological rejection was 37.40% and 89.13% due to corneal angiogenesis.The inreversible immunological rejection was 36.96%(17/46).The immunological rejection involved endothelial type(20 eyes,43 48%),epithelial type (12 eyes,26.09%),stromal type (3 eyes,6.52%),mixed type (11 eyes, 23.91%).Postoperatively,the immunological rejection generally took place from 3 weeks to 3 years.Nearly 46.86% eyes occurred from 3 to 6 months after operation.Conclusion The immunological rejection is very complicated courses for various reasons,it is correlated to the quantity of corneal angiogenesis,the degree of corneal trauma and infectionm,the size of graft,the frequency combined occasion and pattern of operation.
出处 《眼外伤职业眼病杂志》 北大核心 2003年第3期191-192,共2页 Journal of Injuries and Occupational Diseases of the Eye with Ophthalmic Surgeries
关键词 角膜移植术 免疫排斥反应 角膜盲 Corneal transplantation Immunological rejection
  • 相关文献

参考文献5

二级参考文献5

  • 1谢立信.眼前段碱性化学伤的后期治疗(一)[J].眼外伤职业眼病杂志,1994,16(3):237-239. 被引量:4
  • 2谢立信,曹景,董晓光,杨雪萍.环孢霉素A和地塞米松局部应用对角膜移植免疫排斥的疗效观察[J].眼科研究,1995,13(1):24-26. 被引量:8
  • 3谢立信 董晓光 等.穿透性角膜移植术植片混浊的发生规律探讨[J].眼科新进展,1987,3:42-43.
  • 4Guido Bocci,Romano Danesi,Umberto Benelli,Federico Innocenti,Antonello Di Paolo,Stefano Fogli,Mario Del Tacca. Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo[J] 1999,Cancer Chemotherapy and Pharmacology(3):205~212
  • 5Gera Neufeld,Tzafra Cohen,Hela Gitay-Goren,Zoya Poltorak,Shoshana Tessler,Rivka Sharon,Stella Gengrinovitch,Ben-Zion Levi. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants[J] 1996,Cancer and Metastasis Reviews(2):153~158

共引文献29

同被引文献18

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部